Bio Medica Laboratories (NSE:BMLL) Total Equity: ₹147.3 Mil (As of Mar. 2025)


NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
14 GF Score
Price ₹144.10
! 2 Warning Signs
View Full Analysis

What is Bio Medica Laboratories Total Equity?

Bio Medica Laboratories NSE:BMLL +0.49% 14 Total Equity is ₹147.3 Mil as of Mar. 2025. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Bio Medica Laboratories's total equity for the quarter that ended in Mar. 2025 was ₹147.3 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Bio Medica Laboratories Total Equity Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories Total Equity Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
Total Equity
24.40 49.38 147.33

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
Total Equity 24.40 49.38 147.33
NSE:BMLL
14GF Score
Bio Medica Laboratories Ltd NSE:BMLL
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Bio Medica Laboratories's Total Equity for the fiscal year that ended in Mar. 2025 is calculated as

Total Equity=Total Assets(Q: Mar. 2025 )-Total Liabilities(Q: Mar. 2025 )
=391.179-243.849
=147.3

Bio Medica Laboratories's Total Equity for the quarter that ended in Mar. 2025 is calculated as

Total Equity=Total Assets(Q: Mar. 2025 )-Total Liabilities(Q: Mar. 2025 )
=391.179-243.849
=147.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹147.3 Mil mean?
Bio Medica Laboratories (NSE:BMLL) has a Total Equity of ₹147.3 Mil as of Mar. 2025. The total amount of equity as record on a company's balance sheet. View historical data for Bio Medica Laboratories and its competitors.
Is Bio Medica Laboratories' Total Equity too high?
Bio Medica Laboratories' current Total Equity is ₹147.3 Mil. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' Total Equity compare to ISRG and BDX?
Bio Medica Laboratories' Total Equity of ₹147.3 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Bio Medica Laboratories and its competitors. Bio Medica Laboratories's current Total Equity is ₹147.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current Total Equity of ₹147.3 Mil. The current Total Equity is ₹147.3 Mil. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current Total Equity is ₹147.3 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score

Get the complete analysis for NSE:BMLL

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹144.10
Price